Astellas Pharma Net Profit Margin 2012-2020 | ALPMY

Current and historical net profit margin for Astellas Pharma (ALPMY) from 2012 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue. Astellas Pharma net profit margin for the three months ending June 30, 2020 was .
Astellas Pharma Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $8.92B $1.50B 16.85%
2019-06-30 $12.05B $1.89B 15.70%
2018-06-30 $12.15B $1.98B 16.29%
2017-06-30 $11.78B $1.74B 14.74%
2016-09-30 $11.97B $1.86B 15.53%
2016-06-30 $11.72B $1.86B 15.89%
2016-03-31 $11.39B $1.61B 14.11%
2015-12-31 $11.17B $1.51B 13.54%
2015-09-30 $11.22B $1.40B 12.49%
2015-06-30 $11.28B $1.25B 11.09%
2015-03-31 $11.35B $1.24B 10.88%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $26.270B $11.967B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.681B 44.19
Takeda Pharmaceutical (TAK) Japan $52.525B 9.15
Eisai (ESALY) Japan $23.622B 19.96
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $20.091B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.467B 50.28
Grifols, S.A (GRFS) Spain $12.727B 15.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.233B 35.74
Jazz Pharmaceuticals (JAZZ) Ireland $8.333B 13.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.439B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 41.89
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $6.023B 0.00
United Therapeutics (UTHR) United States $5.453B 12.61
Evotec AG (EVTCY) Germany $4.517B 145.40
ChemoCentryx (CCXI) United States $4.051B 0.00
FibroGen (FGEN) United States $3.849B 0.00
Sage Therapeutics (SAGE) United States $3.717B 0.00
PTC Therapeutics (PTCT) United States $3.518B 0.00
Hypermarcas (HYPMY) Brazil $3.483B 12.81
Nektar Therapeutics (NKTR) United States $3.138B 0.00
Revolution Medicines (RVMD) United States $2.661B 0.00
Pacira BioSciences (PCRX) United States $2.371B 62.33
Taro Pharmaceutical Industries (TARO) Israel $2.295B 11.11
Xencor (XNCR) United States $2.260B 0.00
Corcept Therapeutics (CORT) United States $2.063B 18.99
Cronos Group (CRON) Canada $2.040B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.980B 0.00
USANA Health Sciences (USNA) United States $1.805B 15.90
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.561B 14.89
Ironwood Pharmaceuticals (IRWD) United States $1.542B 10.71
Heron Therapeutics (HRTX) United States $1.499B 0.00
Endo (ENDP) Ireland $1.331B 1.97
Trillium Therapeutics (TRIL) Canada $1.277B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.244B 0.00
Zogenix (ZGNX) United States $1.180B 0.00
Karyopharm Therapeutics (KPTI) United States $1.158B 0.00
Translate Bio (TBIO) United States $1.042B 0.00
Indivior (INVVY) United States $1.030B 12.77
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.953B 0.00
Esperion Therapeutics (ESPR) United States $0.899B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.880B 548.13
Tilray (TLRY) Canada $0.856B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.668B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.648B 32.29
Radius Health (RDUS) United States $0.640B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.623B 0.00
VAXART, INC (VXRT) United States $0.617B 0.00
Flexion Therapeutics (FLXN) United States $0.601B 0.00
Siga Technologies (SIGA) United States $0.533B 56.83
Spectrum Pharmaceuticals (SPPI) United States $0.495B 0.00
Molecular Templates (MTEM) United States $0.483B 0.00
Aerie Pharmaceuticals (AERI) United States $0.461B 0.00
Ardelyx (ARDX) United States $0.460B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Akebia Therapeutics (AKBA) United States $0.456B 0.00
Organogenesis Holdings (ORGO) United States $0.444B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
TherapeuticsMD (TXMD) United States $0.403B 0.00
Altimmune (ALT) United States $0.395B 0.00
DURECT (DRRX) United States $0.387B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
Redhill Biopharma (RDHL) Israel $0.362B 0.00
Concert Pharmaceuticals (CNCE) United States $0.353B 0.00
Profound Medical (PROF) Canada $0.342B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.330B 8.18
Jounce Therapeutics (JNCE) United States $0.323B 15.31
Innate Pharma SA (IPHYF) France $0.323B 0.00
MEI Pharma (MEIP) United States $0.321B 0.00
Menlo Therapeutics (VYNE) United States $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.311B 0.00
Lannett Co Inc (LCI) United States $0.282B 6.55
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
CTI BioPharma (CTIC) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Aduro Biotech (KDNY) United States $0.250B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.227B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.220B 0.00
CASI Pharmaceuticals (CASI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.214B 21.14
Nivalis Therapeutics (ALPN) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Aquestive Therapeutics (AQST) United States $0.177B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
OptiNose (OPTN) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.173B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
ProPhase Labs (PRPH) United States $0.104B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.077B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.074B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Recro Pharma (REPH) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.32
Forward Pharma (FWP) Denmark $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
GTx (ONCT) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 25.64
Vical (BBI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00